Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2012
12/06/2012WO2012166712A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
12/06/2012WO2012166659A2 Anti-emr1 antibodies
12/06/2012WO2012166646A1 TARGETING p63 TO RE-ACTIVATE DORMANT RESERVE STEM CELLS IN OLFACTORY EPITHELIUM
12/06/2012WO2012166617A2 Methods, compositions, and kits for the treatment of cancer
12/06/2012WO2012166587A1 Capsule composition for use as immunogen against campylobacter jejuni
12/06/2012WO2012166586A1 SUBSTITUTED 2-BENZYLIDENE-2H-BENZO[b][1,4]THIAZIN-3(4H)-ONES, DERIVATIVES THEREOF, AND THERAPEUTIC USES THEREOF
12/06/2012WO2012166579A1 Synergistic inhibition of erbb2/erbb3 signal pathways in the treatment of cancer
12/06/2012WO2012166493A1 Needle-free administration of prrsv vaccines
12/06/2012WO2012166450A1 Genetic vaccines against hendra virus and nipah virus
12/06/2012WO2012166158A1 Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases
12/06/2012WO2012165925A2 Anti-c-met antibody having hgf activity and use thereof
12/06/2012WO2012165542A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain
12/06/2012WO2012164928A1 H5n1 influenza vaccine and kit for protection against infection
12/06/2012WO2012164497A1 A synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
12/06/2012WO2012164480A1 A vaccine composition capable of inducing memory antibody response from single point immunization
12/06/2012WO2012164372A1 Recombinant anti-canine parvovirus antibody and uses thereof
12/06/2012WO2012164035A1 Method for predicting the risk of developing a colonic neoplasia
12/06/2012WO2012164021A1 Il-21 epitope and il-21 ligands
12/06/2012WO2012163932A1 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
12/06/2012WO2012163848A1 Methods and pharmaceutical compositions for the treatment of crohn's disease
12/06/2012WO2012163833A1 Rhamno-polysaccharide from enterococcus faecium clonal complex 17 and uses thereof
12/06/2012WO2012163817A2 Immunogenic composition
12/06/2012WO2012163811A1 Immunogenic composition
12/06/2012WO2012163810A1 Immunogenic composition
12/06/2012WO2012163533A1 T cell epitope of candida albicans
12/06/2012WO2012163263A1 Reagents and methods for prrsv detection
12/06/2012WO2012163258A1 Combined vaccines for prevention of porcine virus infections
12/06/2012WO2012162828A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012WO2012162731A1 Blood stage malaria vaccine
12/06/2012WO2012142238A3 Compositions and methods for the treatment of tissue fibrosis
12/06/2012WO2012135675A3 Methods for increasing efficacy of folr1 cancer therapy
12/06/2012WO2012058588A4 Novel egfr-binding molecules and immunoconjugates thereof
12/06/2012WO2012051567A3 Obesity-related genes and their proteins and uses thereof
12/06/2012US20120311729 Immunomodulatory Methods and Systems for Treatment and/or Prevention of Atherosclerosis
12/06/2012US20120309054 Products Comprising Inactivated Yeasts or Moulds and Active VHH-Type Antibodies
12/06/2012US20120308660 Nanocoatings for biological materials
12/06/2012US20120308657 Magnetic nanostructures as theranostic agents
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308618 Ic31 nanoparticles
12/06/2012US20120308615 Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunization
12/06/2012US20120308609 6-amino-2--9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
12/06/2012US20120308607 Production and use of human cd124- and cd-116-positive tumor cell lines in the production of allogenic or semi-allogenic immunotherapy agents
12/06/2012US20120308605 Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity
12/06/2012US20120308604 Adjuvant for the preparation of vaccine compositions intended for the prevention of coccidiosis
12/06/2012US20120308603 Dna vaccine against virus of yellow fever
12/06/2012US20120308602 Recombinant RSV Virus Expression Systems And Vaccines
12/06/2012US20120308601 Methods and materials for treating cancer
12/06/2012US20120308600 Polysaccharide immunogens conjugated to e. coli carrier proteins
12/06/2012US20120308599 Vaccine and methods of use against strongyloides stercoralis infection
12/06/2012US20120308598 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins
12/06/2012US20120308597 Serologic correlates of protection against bacillis anthracis infection
12/06/2012US20120308596 Novel streptococcus antigens
12/06/2012US20120308595 Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease
12/06/2012US20120308594 Hcv clade and prototype sequences thereof
12/06/2012US20120308593 Immunological Compositions for HIV
12/06/2012US20120308592 Immunogenic HPV L2-Containing VLPs and Related Compositions, Constructs, and Therapeutic Methods
12/06/2012US20120308591 Tmem22 peptides and vaccines including the same
12/06/2012US20120308590 Imp-3 oligopeptides and vaccines including the same
12/06/2012US20120308589 Sinomenine derivatives, synthetic methods and uses thereof
12/06/2012US20120308588 Neprilysin inhibitors
12/06/2012US20120308587 Neprilysin inhibitors
12/06/2012US20120308586 Composition based on extra virgin olive oils
12/06/2012US20120308585 Methods and compositions for use in cellular therapies
12/06/2012US20120308584 Protein-active agent conjugates and method for preparing the same
12/06/2012US20120308583 Use of gcc ligands
12/06/2012US20120308582 Molecules and methods for modulating tmem16a activities
12/06/2012US20120308581 Compositions and methods for detecting tlr3
12/06/2012US20120308580 Hepatitus b virus specific antibody and usese thereof
12/06/2012US20120308579 Method of making and using a composition for delivering viral immunogen immunoglobulin inhibitor to the nasal pharyngeal membrane
12/06/2012US20120308578 SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSES
12/06/2012US20120308577 Dna vaccines and methods for the prevention of transplantation rejection
12/06/2012US20120308576 Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligands
12/06/2012US20120308575 Full human anti-tnf-alpha monoclonal antibody, preparation method and use thereof
12/06/2012US20120308574 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
12/06/2012US20120308573 Anti-IL-23 Antibodies, Compositions, Methods and Uses
12/06/2012US20120308572 Protofibril-Binding Antibodies and Their Use in Therapeutic and Diagnostic Methods for Parkinson's Disease, Dementia with Lewy Bodies and Other Alpha-Synucleinopathies
12/06/2012US20120308571 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
12/06/2012US20120308570 Methods for treating diseases
12/06/2012US20120308569 Gene products differentially expressed in cancerous cells
12/06/2012US20120308568 Pharmaceutical composition for inhibiting abnormal proliferation of cells
12/06/2012US20120308567 Use of tyrosine kinase inhibitors for treatment of prolactinoma
12/06/2012US20120308566 Use of il-17 receptor a antigen binding proteins
12/06/2012US20120308565 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
12/06/2012US20120308564 Treatment of a metabolic disorder
12/06/2012US20120308563 Regulatory b cells (tbregs) and their use
12/06/2012US20120308562 Methods of treating mesothelioma with a pi3k inhibitor compound
12/06/2012US20120308561 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
12/06/2012US20120308560 Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272
12/06/2012US20120308559 Method of treating hemolytic disease
12/06/2012US20120308558 Methods of Using Antibodies That Bind The Glutamate Ligand Binding Region of Notch1
12/06/2012US20120308557 Immunoglobulin Preparation
12/06/2012US20120308556 Processed ecm materials with enhanced component profiles
12/06/2012US20120308555 Methods and reagents for creating monoclonal antibodies
12/06/2012US20120308554 Vegf-d/vegfr2/3-mediated regulation of dendrites
12/06/2012US20120308516 Use of metallocene compounds for cancer treatment
12/06/2012US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response
12/06/2012US20120308514 Human antibodies that bind human il-12 and methods for producing
12/06/2012US20120308513 Promiscuous her-2/neu cd4 t cell epitopes
12/06/2012US20120308484 Clonal strains of attenuated vaccinia viruses and methods of use thereof
12/06/2012US20120308480 Humanized antibodies against tl1a
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 1823